oral glp-1 medications approved GLP-1s: benefits beyond weight loss Orforglipron Oral GLP-1 Pill Approved

Regulation of the IL-17/Th17 response by NLRP3, neutrophil extracellular traps, and extracellular histones leads to exacerbating bone resorption (Leng et al., 2023)

Not intended for use by persons under 18 years of age, pregnant or breastfeeding women

GLOW Peptide Storage & Handling Storage Reference (All Three Compounds) State Lyophilized (Powder Form) BPC-157 -4 F (-20 C) long-term TB-500 -4 F (-20 C) long-term GHK-Cu -4 F (-20 C) long-term State Reconstituted (Liquid Form) BPC-157 35.6-46.4 F (2-8 C), up to 30 days TB-500 35.6-46.4 F (2-8 C), 1-2 weeks GHK-Cu 35.6-46.4 F (2-8 C), up to 30 days State Appearance BPC-157 Clear TB-500 Clear GHK-Cu May be light blue/green State Freeze reconstituted BPC-157 Aliquots possible TB-500 Do not freeze GHK-Cu Do not freeze TB-500 has the shortest reconstituted-stability window

Theres also the physical side of things